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Summary Leukaemia cutis is a relatively rare manifestation in chronic lymphocytic leukaemia,
characterized by a diverse morphology of skin lesions. We report two patients who
developed zosteriform skin symptoms; however, the histological analysis revealed
leukaemia infiltration as the cause of their symptoms. Contrary to previous reports,
varicella zoster virus DNA was detectable in the lesions. These findings suggest that
varicella zoster virus plays an active role in the development of zosteriform leukae-
mia cutis.
Chronic lymphocytic leukaemia (CLL) is one of the
most common haematological disorders in elderly peo-
ple. Detection of the disease is often an incidental find-
ing during unrelated laboratory tests, although classic
B symptoms (weight loss, fever, night sweats) may also
indicate the development of CLL. The most prevalent
symptoms primarily include: enlargement of the lymph
nodes, hepatosplenomegaly and consequences of bone
marrow suppression-related deficiencies (anaemia,
leucopenia, thrombocytopenia).1
CLL-associated skin symptoms can be classified into
specific and nonspecific lesions: the former are char-
acterized as skin manifestations of a haematological
disorder, while the latter are the results of impaired
immune system functionality.2 Infiltration of the skin
by myeloid/lymphoid tumour cells is defined as
leukaemia cutis, which may be present in several
morphological forms, including papules, vesicles, blis-
ters, infiltrated nodules, and ulcerated or necrotic
lesions.3,4 Cutaneous involvement is generally related
to T-cell derived haematological malignancies, but
approximately 4–20% of B-cell CLL cases also exhibit
leukaemia cutis.3–5
We report two patients with leukaemia cutis with
positive PCR findings for varicella zoster virus (VZV).
Report
Patient 1 was a 71-year-old woman with a 4-year his-
tory of CLL. She had received rituximab and chloram-
bucil therapy due to disease progression. Notably,
3 months following this treatment, zoster-like erup-
tions formed on the right side of her upper torso. The
patient’s skin symptoms did not respond to oral aci-
clovir (400 mg five times/day, prescribed at the
Department of Haematology). Several weeks following
use of aciclovir novel symptoms developed on the
patient’s nose and at the hairline.
On admission, several necrotic papules were
observed on the right side of the patient’s upper torso
and head, in a zosteriform arrangement. Lesions of the
forehead and nape of the neck were similar in appear-
ance. On the nose, a large centrally necrotic papule
was seen, resembling keratoacanthoma (Fig. 1a–d).
Laboratory investigations revealed alterations charac-
teristic of CLL. Histological samples were taken from
the zosteriform lesions of the upper torso and the
keratoacanthoma-like lesion upon the nose. Intra-
venously, aciclovir was initiated at 8 mg/kg three
times daily. Histopathological analysis of both the zos-
teriform and the keratoacanthoma-like lesions showed
a dense, small lymphocytic infiltration indicating cuta-
neous manifestations of CLL (Fig. 1). Samples obtained
from the tumours were also tested for VZV DNA by
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PCR, and despite 2 months of prior antiviral therapy,
VZV DNA was detected in the necrotic infiltrates.
The patient was transferred to the Haematology
ward, in which chlorambucil therapy was initiated
and antiviral treatment was continued. The VZV
symptoms showed slow regression, and 3 months
following hospitalization, only hyperpigmented mac-
ules were present on the upper torso, forehead and
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Figure 1 Patient 1 with chronic lymphocytic leukaemia. (a–c) Necrotic papules in a zosteriform arrangement on (a) the right side of
the chest wall, (b) nape of the neck, (c) and forehead; (d) morphologically different lesion on the tip of the nose, which was centrally
retracted and covered by a necrotic crust. (e–g) Following chlorambucil treatment, there was marked regression of the skin symptoms:
(e) on the chest, only hyperpigmented macules were observable, while the lesions on (f) the nape and (g) forehead were almost com-
pletely healed. (h) There was a residual erythematous papule on the nose, and the previous necrotic crust had disappeared. (i) Histolog-
ical examination depicts dense, dermal infiltrates of small and medium sized lymphocytes in all samples (haematoxylin and eosin,
original magnification 9 400). (j–l) Immunohistochemistry showed the infiltrates to be positive for (j) CD5, (k) CD20 and (l) CD23.
Original magnification (j–l) 9 400.
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nape, while the lesion on the nose also showed
marked improvement (Fig. 1e–h). However, despite
the skin symptoms improving and the chlorambucil
being continued, the CLL continued to progress. The
patient died owing to respiratory insufficiency
3 months after the final cycle of chemotherapy
(7 months after the appearance of zosteriform
lesions).
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Figure 2 Patient 2 with chronic lymphocytic leukaemia. (a–c) Infiltrated papules localized to the left thoracic area (Th1/2 dermatomes).
(d) Histological examination depicts dense, dermal infiltrates of small and medium sized lymphocytes in all samples (haematoxylin and
eosin, original magnification 9 100). (e–g) Immunohistochemistry showed the infiltrates to be positive for (e) CD5, (f) CD20 and (g)
CD23 (original magnification 9 200).
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Patient 2 was a 49-year -old man with 5 years of dis-
ease development, who was treated with fludarabine/
cyclophosphamide chemotherapy because of recurrent
lymphadenopathy. Following two cycles of treatment,
zosteriform cutaneous lesions developed upon the
patient’s back. Despite 2 months of antiviral treatment
(oral aciclovir 800 mg five times/day, followed by
400 mg twice daily), painful, red papules were still
observable in a dermatomal arrangement (Fig. 2a–c).
Histological analysis of the skin biopsy revealed infil-
tration of CLL with necrosis and granulomatous
inflammation. The possibility of cutaneous metastases
was supported by immunohistochemical staining, with
mononuclear cells showing overexpression of CD5 and
CD20 (Fig. 2d–g). Similar to patient 1, VZV DNA was
also detectable in the lesions.
Following the diagnosis of cutaneous CLL lesions,
the patient received one additional cycle of fludara-
bine/cyclophosphamide, but died from pneumonia
1 month following the final round of chemotherapy
(9 months after the formation of skin symptoms).
To date, very few articles have been published high-
lighting zosteriform skin symptoms in patients with
CLL. These symptoms can be divided into nonspecific
(such as granulomatosus reactions, purpura and cuta-
neous vasculitis) and specific (tumorous) lesions.1,3,6
Regarding specificity in the occurrence of lesions, it is
not clear whether the presence of tumorous cells in
the skin should be considered a negative prognostic
factor.1,2,4,7 Occasionally, skin lesions are triggered by
antigenic stimulation, a phenomenon usually not asso-
ciated with disease progession.1,2,4,8 In contrast, infil-
tration of large cells with features of centroblasts and/
or immunoblasts is often a negative prognostic sign.1,9
Although no large cells were observable in our skin
samples, both patients died within a year (7 and
9 months, respectively) following skin infiltration.
Even though a relatively short time elapsed between
the presence of the cutaneous manifestation and the
patients’ deaths, there is insufficient evidence that
would support a causal association between the pres-
ence of cutaneous CLL manifestation and prognosis.
The role of preceding viral infection in tumorous
infiltration is not completely understood. Most reports
have been published on patients with herpes zoster.
There are several theories on the zosteriform arrange-
ment of tumour cells. Tumour cells may spread along
the neurons, or mediators released from damaged
nerves/keratinocytes may attract lymphoid cells to the
skin.5,6,8 Moreover, antigenic stimuli may not only
recruit healthy, but also malignant cells.1,2,4 Several
studies point to the often referred Wolf isotopic
response, in which a new skin disorder develops
within the scars and/or tissue from a previous, unre-
lated disease.6 Interestingly, the zosteriform arrange-
ment can be a feature of other tumours, such as
mammalian and colon adenocarcinomas, or metastatic
melanoma.4
Detectability of VZV in lesional samples is also the
subject of extensive discussion. While most studies in
which VZV detection was attempted by PCR originat-
ing from zosteriform skin lesions yielded negative
results,4,5,7,8 there are several publications in which
VZV DNA appears in skin lesions.10 Moreover, the
presence of herpes simplex DNA was also described in
cutaneous manifestations of CLL.2
In conclusion, we report two cases of zosteriform
cutaneous infiltration. Our results indicate that the
presence of VZV plays an important factor in the
development and maintenance of cutaneous infiltrates.
In contrast to previous reports, the cutaneous lesions
in our patients showed distinct VZV DNA positivity,
suggesting that VZV is implicated in immunological
processes leading to leukaemia cutis.
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Learning points
• Two patients with CLL developed zosteriform
lesions.
• Contrary to previous reports, it was shown that
VZV DNA may be detectable in the cutaneous
involvement of CLL.
• VZV may likely be an active participant in the
cutaneous infiltration of neoplastic lymphoid
cells.
• It is unclear whether a disease-specific cuta-
neous infiltration should be considered as a nega-
tive prognostic factor.
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